KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Total Non-Current Liabilities (2016 - 2025)

Cvs Health (CVS) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $173.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities rose 0.77% year-over-year to $173.4 billion, compared with a TTM value of $173.4 billion through Dec 2025, up 0.77%, and an annual FY2025 reading of $173.4 billion, up 0.77% over the prior year.
  • Total Non-Current Liabilities was $173.4 billion for Q4 2025 at Cvs Health, down from $177.5 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $177.5 billion in Q3 2025 and bottomed at -$78.3 billion in Q3 2022.
  • Average Total Non-Current Liabilities over 5 years is $153.0 billion, with a median of $168.1 billion recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities tumbled 149.54% in 2022, then surged 317.95% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $155.7 billion in 2021, then decreased by 3.81% to $149.8 billion in 2022, then increased by 11.42% to $166.9 billion in 2023, then rose by 3.1% to $172.1 billion in 2024, then grew by 0.77% to $173.4 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for CVS at $173.4 billion in Q4 2025, $177.5 billion in Q3 2025, and $176.0 billion in Q2 2025.